This research material is not an investigational drug product, has not been evaluated by the FDA for any use, and is not intended for clinical, diagnostic, or veterinary applications
As of the date and present studies circulating, BPC 157 has few to no side effects
"Homocysteine levels in morbidly obese patients: its association with waist circumference and insulin resistance"
Ex vivo studies using dissected hair follicle organ cultures allow researchers to observe the effects of GHK-Cu on the hair cycle itself, particularly its potential to prolong the anagen (growth) phase
[1] It is important to understand that FDA-approved tirzepatide is supplied as a pre-filled, single-dose pen containing a sterile solution ready for injection
Mislabeled Vials: The majority of products tested were found to be completely mislabeled, containing a different substance entirely or no active ingredient at all